- Current report filing (8-K)
December 10 2008 - 10:51AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934.
Date
of Report: December 10, 2008
(Date
of earliest event reported)
Oragenics,
Inc
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
FL
|
|
001-38122
|
|
59-3410522
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
Number)
|
|
|
|
13700
Progress Blvd
|
|
32615
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
386-418-4018
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
Name or Former Address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM
8.01 OTHER EVENTS
On
December 10, 2008, Oragenics, Inc. (the “Company”) d/b/a ONI BioPharma
Inc.(Alternext US* “ONI”) received notice from Alternext Paris that the
admission committee had reviewed the Company’s listing application and upon
recommendation by the Company’s listing sponsor Bryan Garnier, among other
factors, had admitted the Company to be listed on their exchange.
The
trading symbol will be “ALONI” and trading will commence on Alternext Paris on
December 15, 2008.
ONI
BioPharma is the first United States based company to be listed on the Alternext
Paris exchange.
A copy of
the press release announcing the listing on Alternext Paris is furnished as
Exhibit 99.1 to this Current Report on Form 8-K. We do not
intend for the information referenced as being available on our website in the
press release to be a part of this Form 8-K.
* The
American Stock Exchange was acquired by NYSE Euronext on October 1, 2008,
and its name was changed to NYSE Alternext US LLC.
Item
9.01 FINANCIAL INFORMATION AND EXHIBITS
Number
|
Description
|
99.1
|
Press
release issued December 10, 2008 as to Alternext Paris
notice
|
SIGNATURES
In
accordance with the requirements of the Exchange Act, the registrant caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized
on this 10
th
day of
December, 2008.
|
ORAGENICS,
INC.
|
|
|
|
|
|
|
By:
|
/s/
David B. Hirsch
|
|
|
|
David B.
Hirsch
|
|
|
|
Chief
Financial Officer
|
|
|
|
|
|
Oragenics (AMEX:ONI)
Historical Stock Chart
From Apr 2024 to May 2024
Oragenics (AMEX:ONI)
Historical Stock Chart
From May 2023 to May 2024